PRVA is currently covered by 9 analysts with average potential upside of $10.41 (36.83%) backed by 0 price targets and 49 ratings. Documented since 24-May-2021. Analyst's average stock valuation to be materialised ratio is 62.69% with an average time for price targets to be met of 93.22 days.
Most recent stock forecast was given by JAILENDRA SINGH from CREDIT SUISSE on 16-Nov-2022.
Highest price target for PRVA is 45, Lowest price target is 21, average price target is 33.
Currently, out of the existing stock ratings of PRVA - 45 which are a Buy (91.84%), 4 which are a Hold (8.16%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
41
$13.55 (49.36%)
54
4 months 15 days ago
2/5 (40%)
$12.11 (37.12%)
32
Buy
42
$14.55 (53.01%)
36
4 months 16 days ago
2/3 (66.67%)
$11.16 (40.74%)
68
Buy
43
$15.55 (56.65%)
50
4 months 20 days ago
3/8 (37.5%)
$12.51 (42.25%)
43
Buy
39
$11.55 (42.08%)
46
4 months 20 days ago
4/8 (50%)
$12.79 (50.16%)
230
Buy
44
$16.55 (60.29%)
35
7 months 19 days ago
3/4 (75%)
$6.16 (22.05%)
150
What is PRVA(Privia Health Group Inc) average time for price targets to be met?
Which analyst has the current highest performing score on PRVA(Privia Health Group Inc) with a proven track record?
